These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
644 related items for PubMed ID: 28620583
21. Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites. Butler NS, Schmidt NW, Harty JT. J Immunol; 2010 Mar 01; 184(5):2528-38. PubMed ID: 20097864 [Abstract] [Full Text] [Related]
22. Medicine: knockout malaria vaccine? Ménard R. Nature; 2005 Jan 13; 433(7022):113-4. PubMed ID: 15650722 [No Abstract] [Full Text] [Related]
23. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies. Good MF. Trends Immunol; 2005 Jun 13; 26(6):295-7. PubMed ID: 15922944 [Abstract] [Full Text] [Related]
29. A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites. van Schaijk BC, Ploemen IH, Annoura T, Vos MW, Foquet L, van Gemert GJ, Chevalley-Maurel S, van de Vegte-Bolmer M, Sajid M, Franetich JF, Lorthiois A, Leroux-Roels G, Meuleman P, Hermsen CC, Mazier D, Hoffman SL, Janse CJ, Khan SM, Sauerwein RW. Elife; 2014 Nov 19; 3():. PubMed ID: 25407681 [Abstract] [Full Text] [Related]
30. Varying Immunizations With Plasmodium Radiation-Attenuated Sporozoites Alter Tissue-Specific CD8+ T Cell Dynamics. Frank R, Gabel M, Heiss K, Mueller AK, Graw F. Front Immunol; 2018 Nov 19; 9():1137. PubMed ID: 29892289 [Abstract] [Full Text] [Related]
31. Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization. Nganou-Makamdop K, Ploemen I, Behet M, Van Gemert GJ, Hermsen C, Roestenberg M, Sauerwein RW. Parasite Immunol; 2012 Dec 19; 34(12):562-9. PubMed ID: 23171040 [Abstract] [Full Text] [Related]
33. A Plasmodium Parasite with Complete Late Liver Stage Arrest Protects against Preerythrocytic and Erythrocytic Stage Infection in Mice. Vaughan AM, Sack BK, Dankwa D, Minkah N, Nguyen T, Cardamone H, Kappe SHI. Infect Immun; 2018 May 19; 86(5):. PubMed ID: 29440367 [Abstract] [Full Text] [Related]
34. Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells. Longley RJ, Bauza K, Ewer KJ, Hill AV, Spencer AJ. PLoS One; 2015 May 19; 10(3):e0119880. PubMed ID: 25822951 [Abstract] [Full Text] [Related]
35. The Development of Whole Sporozoite Vaccines for Plasmodium falciparum Malaria. Itsara LS, Zhou Y, Do J, Grieser AM, Vaughan AM, Ghosh AK. Front Immunol; 2018 May 19; 9():2748. PubMed ID: 30619241 [Abstract] [Full Text] [Related]
36. Protective efficacy and safety of liver stage attenuated malaria parasites. Kumar H, Sattler JM, Singer M, Heiss K, Reinig M, Hammerschmidt-Kamper C, Heussler V, Mueller AK, Frischknecht F. Sci Rep; 2016 May 31; 6():26824. PubMed ID: 27241521 [Abstract] [Full Text] [Related]
37. A Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate. Jaijyan DK, Singh H, Singh AP. J Biol Chem; 2015 Aug 07; 290(32):19496-511. PubMed ID: 25960542 [Abstract] [Full Text] [Related]
38. Defining rules of CD8(+) T cell expansion against pre-erythrocytic Plasmodium antigens in sporozoite-immunized mice. Billman ZP, Kas A, Stone BC, Murphy SC. Malar J; 2016 Apr 26; 15():238. PubMed ID: 27113469 [Abstract] [Full Text] [Related]
39. Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy. Leitner WW, Bergmann-Leitner ES, Angov E. Malar J; 2010 May 27; 9():145. PubMed ID: 20507620 [Abstract] [Full Text] [Related]
40. Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. Weiss WR, Jiang CG. PLoS One; 2012 May 27; 7(2):e31247. PubMed ID: 22355349 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]